CN Patent

CN1740150A — 2－氧代－1－吡咯烷衍生物、其制备方法和用途

Assigned to UCB SA · Expires 2006-03-01 · 20y expired

What this patent protects

本发明涉及化合物(2S)－2－[(4S)－4－(2，2－二氟乙烯基)－2－氧代吡咯烷基]丁酰胺。本发明的化合物特别适用于治疗神经性疾病例如癫痫。

USPTO Abstract

本发明涉及化合物(2S)－2－[(4S)－4－(2，2－二氟乙烯基)－2－氧代吡咯烷基]丁酰胺。本发明的化合物特别适用于治疗神经性疾病例如癫痫。

Drugs covered by this patent

Briviact (BRIVARACETAM) · UCB

Patent Metadata

Patent number: CN1740150A
Jurisdiction: CN
Classification: —
Expires: 2006-03-01
Drug substance claim: No
Drug product claim: No
Assignee: UCB SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.